Cargando…
Critical analysis of the prescription and evaluation of protein kinase inhibitors for oncology in Germany
The prices of oncology drugs have been rising progressively in recent years. Despite accounting for only a small share of prescriptions, oncology drugs are the most expensive drugs on the market. However, the association between drug price and clinical benefit often remains questionable. Therefore,...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497443/ https://www.ncbi.nlm.nih.gov/pubmed/37014400 http://dx.doi.org/10.1007/s00210-023-02475-9 |